Disrupting is the buzz word for game changing tech and Google is disrupting aging. I haven’t heard it used in association with aging before but go ahead Google, disrupt away. It’s pretty darn awesome to disrupt aging but what does this…
genetics
Two issues here. 23andme’s marketing strategy changed dramatically in the recent past. It became “in your face” in a retail consumer manner, morphing quickly from a more subtle place. Genetic testing was more mainstream now than even a year…
A recap of the past day: 23andme has stopped including the health reports section of the test because apparently people are not smart enough to understand the results as presented: High, Low, and Typical risk category. The FDA is…
More thinking on this subject. Over on The Economist website someone wrote in that United Healthcare is behind the FDA’s attack on 23andme. Apparently they have a long history of complaints about 23. And they have friends at the…
People have a right to all information about their bodies and health. Real stats, genetics, risks, things that can be done that don’t require paying someone in a white coat to do. It belongs to us. “They” can medicalize…
I had my thumb pricked at BioCurious by Exogen Bio CEO and co-founder Sylvain Costes, PhD who is also at Lawrence Berkeley Labs. The white blood cells will be analyzed to quantify the number of DNA breaks. The number…